Tags

Type your tag names separated by a space and hit enter

Polycystic ovary syndrome and the metabolic syndrome.
J Med Assoc Thai. 2004 Oct; 87 Suppl 3:S189-93.JM

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrinological disorder in female reproductive age. Insulin resistance (IR) and compensatory hyperinsulinemia seem to be the main pathophysiologies of this syndrome. Therefore, PCOS is at risk for abnormal glucose tolerance, dyslipidemia, central obesity and hypertension. Also, plasminogen activator-inhibitor-1 (PAL-1), hemostatic factor and C-reactive protein (CRP), inflammatory factor have been reported in PCOS women. The metabolic syndrome (MS), a clustering of several metabolic abnormalities, is more prevalent in PCOS. One-third to 46% of PCOS women with MS have been reported. Since these metabolic abnormalities as well as MS are the important risk factors of cardiovascular disease (CVD), PCOS is at risk for CVD.

Authors+Show Affiliations

Weerakiet S
Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.

MeSH

Blood GlucoseBody Mass IndexCardiovascular DiseasesDyslipidemiasFemaleGlucose Tolerance TestHumansHyperinsulinismHypertensionInsulinInsulin ResistanceMetabolic SyndromePolycystic Ovary SyndromeRisk Factors

Pub Type(s)

Journal Article

Language

eng

PubMed ID

21213522

Citation

Weerakiet, Sawaek. "Polycystic Ovary Syndrome and the Metabolic Syndrome." Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, vol. 87 Suppl 3, 2004, pp. S189-93.
Weerakiet S. Polycystic ovary syndrome and the metabolic syndrome. J Med Assoc Thai. 2004;87 Suppl 3:S189-93.
Weerakiet, S. (2004). Polycystic ovary syndrome and the metabolic syndrome. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, 87 Suppl 3, S189-93.
Weerakiet S. Polycystic Ovary Syndrome and the Metabolic Syndrome. J Med Assoc Thai. 2004;87 Suppl 3:S189-93. PubMed PMID: 21213522.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Polycystic ovary syndrome and the metabolic syndrome. A1 - Weerakiet,Sawaek, PY - 2011/1/11/entrez PY - 2004/10/1/pubmed PY - 2011/3/18/medline SP - S189 EP - 93 JF - Journal of the Medical Association of Thailand = Chotmaihet thangphaet JO - J Med Assoc Thai VL - 87 Suppl 3 N2 - Polycystic ovary syndrome (PCOS) is a common endocrinological disorder in female reproductive age. Insulin resistance (IR) and compensatory hyperinsulinemia seem to be the main pathophysiologies of this syndrome. Therefore, PCOS is at risk for abnormal glucose tolerance, dyslipidemia, central obesity and hypertension. Also, plasminogen activator-inhibitor-1 (PAL-1), hemostatic factor and C-reactive protein (CRP), inflammatory factor have been reported in PCOS women. The metabolic syndrome (MS), a clustering of several metabolic abnormalities, is more prevalent in PCOS. One-third to 46% of PCOS women with MS have been reported. Since these metabolic abnormalities as well as MS are the important risk factors of cardiovascular disease (CVD), PCOS is at risk for CVD. SN - 0125-2208 UR - https://www.unboundmedicine.com/medline/citation/21213522/Polycystic_ovary_syndrome_and_the_metabolic_syndrome_ L2 - https://medlineplus.gov/metabolicsyndrome.html DB - PRIME DP - Unbound Medicine ER -